| Hydraulically amplified self-healing electrostatic actuators with muscle-like performance E Acome, SK Mitchell, TG Morrissey, MB Emmett, C Benjamin, M King, ... Science 359 (6371), 61-65, 2018 | 890 | 2018 |
| Multicenter study of outcomes with ceftazidime-avibactam in patients with carbapenem-resistant Enterobacteriaceae infections M King, E Heil, S Kuriakose, T Bias, V Huang, C El-Beyrouty, D McCoy, ... Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00449-17, 2017 | 128 | 2017 |
| Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study JC Gallagher, MJ Satlin, A Elabor, N Saraiya, EK McCreary, E Molnar, ... Open forum infectious diseases 5 (11), ofy280, 2018 | 113 | 2018 |
| The minority spotlight effect JR Crosby, M King, K Savitsky Social Psychological and Personality Science 5 (7), 743-750, 2014 | 48 | 2014 |
| Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer M Friedlander, P Butow, M Stockler, C Gainford, J Martyn, A Oza, ... International Journal of Gynecologic Cancer 19 (Suppl 2), 2009 | 40 | 2009 |
| Early experience with eravacycline for complicated infections S Alosaimy, KC Molina, KC Claeys, J Andrade, J Truong, MA King, ... Open Forum Infectious Diseases 7 (5), ofaa071, 2020 | 34 | 2020 |
| Guidelines for diagnosis and management of infective endocarditis in adults: a WikiGuidelines group consensus statement EG McDonald, G Aggrey, AT Aslan, M Casias, N Cortes-Penfield, ... JAMA network open 6 (7), e2326366-e2326366, 2023 | 22 | 2023 |
| Vibrio vulnificus Infections From a Previously Nonendemic Area M King, L Rose, H Fraimow, M Nagori, M Danish, K Doktor Annals of Internal Medicine 171 (7), 520-521, 2019 | 22 | 2019 |
| Clinical outcomes of eravacycline in patients treated predominately for carbapenem-resistant Acinetobacter baumannii S Alosaimy, T Morrisette, AM Lagnf, LM Rojas, MA King, BM Pullinger, ... Microbiology Spectrum 10 (5), e00479-22, 2022 | 13 | 2022 |
| Multidisciplinary teams for the management of infective endocarditis: a systematic review and meta-analysis AS Roy, H Hagh-Doust, A Abdul Azim, J Caceres, JT Denholm, MQ Dong, ... Open Forum Infectious Diseases 10 (9), ofad444, 2023 | 11 | 2023 |
| Medical Management of Endocarditis Caused by Stenotrophomonas maltophilia: A Case Report S Shah, M King, L Rose Journal of Pharmacy Practice 32 (6), 683-686, 2019 | 10 | 2019 |
| The minority spotlight effect. Social Psychological and Personality Science, 5 (7), 743–750 JR Crosby, M King, K Savitsky | 10 | 2014 |
| Eravacycline, the first four years: Health outcomes and tolerability data for 19 hospitals in 5 US regions from 2018 to 2022 AJ Kunz Coyne, S Alosaimy, K Lucas, AM Lagnf, T Morrisette, KC Molina, ... Microbiology Spectrum 12 (1), e02351-23, 2024 | 7 | 2024 |
| Outcomes With Ceftazidime/Avibactam in Patients With Carbapenem-Resistant Enterobacteriaceae (CRE) Infections: A Multi-center Study M King, E Heil, S Kuriakose, T Bias, V Huang, C El-Beyrouty, D McCoy, ... Open Forum Infectious Diseases 3 (suppl_1), 2047, 2016 | 7 | 2016 |
| Dynamic interplay of pharmacy learners during a solid organ transplantation learning experience JH Sin, H Li, N Jandovitz, M King, DS Tsapepas Journal of Pharmacy Practice 31 (3), 347-352, 2018 | 6 | 2018 |
| 1062. Daptomycin/Ceftaroline in combination vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia M Fox, K Zeqollari, G Lee, L Pontiggia, D Byrne, J Adams, M King, L Rose Open Forum Infectious Diseases 5 (Suppl 1), S318, 2018 | 5 | 2018 |
| Inappropriate use of aztreonam R Steiner, M King, D Byrne, L Rose American Journal of Therapeutics 28 (1), e14-e18, 2021 | 3 | 2021 |
| Network churn: A theoretical and empirical consideration of a dynamic process on performance MK Kneeland New York University, 2019 | 3 | 2019 |
| Cities M King, M Carrigan World Book, 2019 | 3 | 2019 |
| 2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study A Elabor, E Molnar, M King, J Gallagher, ... Open Forum Infectious Diseases 5 (suppl_1), S709-S710, 2018 | 3 | 2018 |
